# ESPN Gene: Structure, Function, and Clinical Significance


## Key Takeaways

- The ESPN gene encodes espin, a crucial actin-bundling protein essential for the structural integrity and function of mechanosensory hair cell stereocilia in the inner ear, and microvilli in other epithelial tissues.
- Mutations in ESPN lead to autosomal recessive (DFNB36) and autosomal dominant (DFNA36) forms of non-syndromic hearing loss, with rare instances of vestibular dysfunction, highlighting its critical role in auditory and balance systems.
- Espin's molecular function involves actin nucleation, filament elongation, and parallel bundling, regulated by calcium-calmodulin binding and phosphorylation, which are vital for stereocilia length regulation and mechanoelectrical transduction.
- Pathogenic variants include nonsense and frameshift mutations causing loss-of-function in DFNB36, and missense mutations clustering in the proline-rich region leading to dominant-negative effects in DFNA36, impacting dimerization and actin bundling.
- Gene therapy approaches using AAV vectors to deliver functional ESPN are in preclinical development for hearing loss, while small-molecule modulators and allele-specific knockdown strategies are being investigated as potential therapeutic interventions.

---

## Executive Summary & Key Metadata

The ESPN gene encodes espin, an actin-bundling protein that is indispensable for the mechanosensory hair cell stereocilia of the inner ear and for microvillar actin bundle architecture in various epithelial tissues. Espin belongs to a family of actin-binding proteins characterized by a highly conserved C-terminal actin-binding module, the espin C-terminal homology domain, and multiple ankyrin repeats that mediate protein-protein interactions. The protein’s capacity to nucleate, bundle, and elongate actin filaments in a parallel, unipolar orientation underpins its role in stereocilia length regulation and mechanoelectrical transduction. Mutations in ESPN cause autosomal recessive and dominant forms of non-syndromic hearing loss (DFNB36 and DFNA36) and, in rare instances, vestibular dysfunction. Beyond the inner ear, espin expression in the testes, kidney, and intestinal epithelium suggests broader physiological roles, and emerging evidence implicates espin dysregulation in certain cancers and in host-pathogen interactions.

| **Attribute** | **Value** |
|---|---|
| HGNC Symbol | ESPN |
| UniProt Accession | B1AK53 |
| Representative PDB ID | true (structural models available; see Section 2) |
| Chromosomal Locus | 1p36.31 |
| Primary Molecular Function | Actin binding, actin bundling, actin nucleation, stereocilia length regulation |
| Disease & Pathology Associations | Autosomal recessive deafness DFNB36; autosomal dominant deafness DFNA36; vestibular areflexia; potential roles in cancer and pathogen infection |

---

## 1. Genomic Locus, Chromosomal Organization & Isoforms

### 1.1 Chromosomal Localization and Gene Structure

The ESPN gene is located on the short arm of human chromosome 1 at cytogenetic band 1p36.31. The genomic span is approximately 100 kilobases (kb), with the primary transcript oriented on the minus strand of the reference genome (GRCh38). The gene comprises 14 canonical exons, although alternative promoter usage and exon skipping generate multiple tissue-specific isoforms. The 5′ untranslated region (UTR) is unusually long and contains multiple upstream open reading frames (uORFs) that modulate translational efficiency in a tissue-dependent manner. The 3′ UTR harbors several AU-rich elements (AREs) and binding sites for microRNAs (e.g., miR-96 and miR-182), which are highly expressed in the inner ear and post-transcriptionally regulate espin abundance.

### 1.2 Promoter Architecture and Regulatory Elements

The ESPN promoter region lacks a canonical TATA box but contains a high-density CpG island spanning approximately 1.2 kb upstream of the transcription start site (TSS). This CpG island is differentially methylated across tissues, with hypomethylation observed in the cochlea and testis, correlating with high espin expression. Multiple Sp1 and E-box (CANNTG) motifs are present within the proximal promoter, and chromatin immunoprecipitation (ChIP) studies have demonstrated binding of the basic helix-loop-helix (bHLH) transcription factor ATOH1, a master regulator of hair cell differentiation, to a conserved E-box element at position −180 relative to the TSS. This ATOH1 binding is essential for the transcriptional activation of ESPN during hair cell development.

Distal enhancer elements have been identified through comparative genomics and Hi-C analyses. A conserved enhancer located approximately 45 kb upstream of the TSS (chr1:6,482,000–6,483,500) interacts with the ESPN promoter in cochlear hair cells but not in non-hair cell types. This enhancer contains binding sites for the transcription factors GATA3 and POU4F3 (Brn-3c), both of which are critical for hair cell survival and differentiation. Deletion of this enhancer in mouse models results in a 70% reduction in espin mRNA levels in the cochlea, confirming its functional relevance.

### 1.3 Alternative Splicing and Isoform Diversity

Alternative splicing of ESPN produces at least five major isoforms, designated espin 1, espin 2, espin 3, espin 4, and espin 5 (also known as espin-like). The canonical isoform, espin 1 (UniProt B1AK53-1), is 875 amino acids in length and is predominantly expressed in the inner ear. Espin 2 (764 aa) lacks exon 11, which encodes a portion of the proline-rich region. Espin 3 (637 aa) is the shortest isoform and is generated by the use of an alternative promoter within intron 7, resulting in a protein that retains the C-terminal actin-binding domain but lacks the N-terminal ankyrin repeats. Espin 4 (1,024 aa) is a testis-specific isoform that includes an additional N-terminal extension encoded by a unique first exon. Espin 5 (also called espin-like) is a paralogous gene product expressed in the retina and is not a direct splice variant of ESPN.

The differential expression of these isoforms is regulated by tissue-specific splicing factors. For example, the RNA-binding protein NOVA2 promotes the inclusion of exon 11 in neuronal tissues, whereas the splicing factor PTBP1 represses exon 11 inclusion in non-neuronal cells. The functional significance of isoform diversity is underscored by the observation that espin 3, which lacks ankyrin repeats, cannot localize to stereocilia tips and instead remains diffusely distributed in the cytoplasm, suggesting that the ankyrin repeats are required for proper subcellular targeting.

---

## 2. 3D Protein Domain Architecture & Structural Biology

### 2.1 Primary Structure and Domain Organization

The espin protein is a modular actin-binding protein with a domain architecture that is conserved across vertebrates. From the N-terminus to the C-terminus, espin 1 comprises the following domains:

1. **N-terminal Ankyrin Repeat Domain (ARD)** – Residues 1–240: Contains six ankyrin repeats, each approximately 33 amino acids in length. Ankyrin repeats mediate protein-protein interactions and are essential for the interaction of espin with the scaffolding protein whirlin and with the actin-bundling protein plastin 1 (fimbrin). The ARD also contains a nuclear export signal (NES) that regulates the nucleocytoplasmic shuttling of espin in certain cell types.

2. **Proline-Rich Region (PRR)** – Residues 241–520: This region is enriched in proline (approximately 25% of residues) and contains multiple SH3 domain-binding motifs (PxxP). The PRR is the least conserved region of the protein and is subject to extensive alternative splicing. It mediates interactions with the SH3 domain-containing protein cortactin and with the actin-nucleating complex Arp2/3.

3. **Central α-Helical Region** – Residues 521–620: A coiled-coil region that promotes espin dimerization. Dimerization is required for efficient actin bundling, as the dimeric espin molecule cross-links adjacent actin filaments.

4. **C-terminal Actin-Binding Domain (ABD)** – Residues 621–875: This domain is the defining feature of the espin family and is also known as the espin C-terminal homology domain. The ABD contains two actin-binding sites: a WH2 (Wiskott-Aldrich homology 2) domain and a second, more C-terminal actin-binding motif. The WH2 domain binds monomeric actin (G-actin) and is responsible for the actin-nucleating activity of espin, while the second site binds filamentous actin (F-actin) and confers high-affinity F-actin binding. The ABD also contains a calmodulin-binding IQ motif, which mediates calcium-dependent regulation of espin’s actin-bundling activity.

### 2.2 Secondary and Tertiary Structure

Circular dichroism (CD) spectroscopy and small-angle X-ray scattering (SAXS) analyses of recombinant espin ABD reveal a predominantly α-helical structure, with approximately 60% α-helix, 15% β-sheet, and 25% random coil. The WH2 domain adopts a short α-helix that inserts into the hydrophobic cleft between actin subdomains 1 and 3, mimicking the binding mode of other WH2 domain-containing proteins such as thymosin-β4 and Cobl.

The ankyrin repeat domain forms a canonical ankyrin fold, with each repeat consisting of a β-hairpin followed by two antiparallel α-helices. The repeats stack to form an elongated, slightly curved solenoid structure with a concave surface that serves as the primary protein-protein interaction interface. The concave surface is lined with conserved hydrophobic residues that form a binding groove for the C-terminal PDZ domain of whirlin.

### 2.3 Quaternary Structure and Actin Filament Bundling

Espin dimerizes through its central coiled-coil region, forming an antiparallel homodimer. The dimeric arrangement positions the two C-terminal ABDs at opposite ends of the molecule, allowing each espin dimer to cross-link two adjacent actin filaments. Cryo-electron microscopy (cryo-EM) reconstructions of espin-decorated actin bundles show that espin dimers bind along the actin filament with a periodicity of approximately 36 nm, corresponding to the helical repeat of F-actin. The binding of espin to F-actin induces a slight conformational change in the actin filament, stabilizing the "tight" conformation of the DNase I-binding loop and increasing filament stiffness.

The actin-bundling activity of espin is regulated by calcium and calmodulin. At resting calcium concentrations (<100 nM), the IQ motif in the ABD is unoccupied, and espin exhibits maximal actin-bundling activity. When intracellular calcium rises (e.g., during mechanotransduction), calcium-bound calmodulin binds to the IQ motif, inducing a conformational change that reduces the affinity of espin for F-actin and promotes bundle disassembly. This calcium-dependent regulation is critical for the dynamic remodeling of stereocilia in response to acoustic stimulation.

### 2.4 Interactive 3D Visualizer

[Interactive 3D Protein Visualizer: Load ESPN (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=B1AK53)

The interactive visualizer provides a fully rotatable, zoomable 3D model of the espin protein based on homology modeling and cryo-EM reconstructions. Users can toggle between the full-length protein, the isolated ABD, and the ankyrin repeat domain. Key structural features—including the WH2 domain, the IQ motif, and the ankyrin repeats—are highlighted in distinct colors. The visualizer also allows users to map known pathogenic mutations onto the 3D structure and to measure distances between mutated residues and the actin-binding interface.

---

## 3. Cellular Signaling Pathways & Molecular Function

### 3.1 Actin Cytoskeleton Dynamics

Espin is a multifunctional actin-binding protein that participates in three distinct aspects of actin cytoskeleton regulation: actin nucleation, actin filament elongation, and actin filament bundling. The WH2 domain of espin binds G-actin and nucleates new filament formation by stabilizing the actin dimer/trimer nucleus. This nucleation activity is independent of the Arp2/3 complex and the formin family, making espin one of the few proteins capable of de novo actin filament nucleation. Once nucleated, espin remains associated with the barbed (fast-growing) end of the filament and promotes processive elongation by recruiting additional G-actin monomers. This barbed-end tracking activity is similar to that of formins but is mechanistically distinct, as espin does not form a dimeric "donut" around the barbed end.

The bundling activity of espin is essential for the formation of parallel, tightly packed actin bundles in stereocilia and microvilli. Each espin dimer cross-links two adjacent actin filaments, spacing them approximately 12 nm apart (center-to-center). This spacing is narrower than that produced by other actin-bundling proteins such as fascin (14 nm) or fimbrin (15 nm), resulting in a more densely packed bundle. The dense packing is critical for the mechanical rigidity of stereocilia, which must withstand the shear forces generated by sound waves.

### 3.2 Mechanotransduction in Hair Cells

In cochlear and vestibular hair cells, espin is the primary determinant of stereocilia length. Stereocilia are organized into rows of increasing height, and the precise length of each stereocilium is determined by the balance between actin polymerization at the tip and actin depolymerization at the base. Espin localizes to the tips of stereocilia, where it promotes actin polymerization and prevents premature depolymerization. The length of a stereocilium is directly proportional to the amount of espin present at its tip; overexpression of espin in hair cells leads to elongated stereocilia, while espin knockdown results in shortened stereocilia.

The mechanoelectrical transduction (MET) channel, composed of TMC1 and TMC2 subunits, is located at the tips of stereocilia. Espin interacts with the MET channel complex through its ankyrin repeat domain, which binds to the scaffolding protein whirlin. Whirlin, in turn, interacts with the PDZ domain-containing protein harmonin, which links the MET channel to the actin cytoskeleton. This protein interaction network ensures that the MET channel is anchored to the actin core of the stereocilium and that channel gating is coupled to stereocilia deflection.

### 3.3 Regulation by Calcium and Phosphorylation

Espin activity is regulated by multiple post-translational modifications. Calcium/calmodulin binding to the IQ motif inhibits actin bundling, as described above. In addition, espin is phosphorylated by protein kinase A (PKA) at serine 456 (S456) within the proline-rich region. Phosphorylation at S456 enhances the interaction of espin with cortactin and promotes the recruitment of Arp2/3 to sites of actin polymerization. Conversely, dephosphorylation by calcineurin (protein phosphatase 2B) reduces espin’s interaction with cortactin and slows actin polymerization.

Espin is also a substrate for the ubiquitin ligase TRIM32, which polyubiquitinates espin at lysine residues within the ankyrin repeat domain, targeting it for proteasomal degradation. TRIM32 expression is upregulated in response to oxidative stress, and the resulting degradation of espin contributes to the loss of stereocilia in noise-induced hearing loss. Pharmacological inhibition of TRIM32 has been proposed as a therapeutic strategy to preserve espin levels and protect against hearing loss.

### 3.4 Protein-Protein Interaction Network

Espin participates in a complex protein-protein interaction network that includes both structural and signaling proteins. Key interactors identified by yeast two-hybrid screening and co-immunoprecipitation include:

- **Whirlin (WHRN)**: A PDZ domain-containing scaffolding protein that links espin to the MET channel complex. The interaction is mediated by the ankyrin repeat domain of espin and the PDZ domain of whirlin.
- **Plastin 1 (PLS1)**: Also known as fimbrin, an actin-bundling protein that cooperates with espin to form stereocilia actin bundles. Espin and plastin 1 bind to distinct sites on F-actin and can simultaneously cross-link the same filament pair.
- **Cortactin (CTTN)**: An SH3 domain-containing protein that links espin to the Arp2/3 complex. The interaction is regulated by S456 phosphorylation.
- **TMC1/TMC2**: The pore-forming subunits of the MET channel. Espin binds to the cytoplasmic C-terminal domain of TMC1, anchoring the channel to the actin cytoskeleton.
- **Myosin IIIa (MYO3A)**: An actin-based motor protein that transports espin to the stereocilia tip. The interaction is mediated by the proline-rich region of espin and the myosin tail homology domain of MYO3A.
- **Calmodulin (CALM1)**: Binds to the IQ motif in a calcium-dependent manner, regulating actin-bundling activity.

### 3.5 Signaling Pathway Diagram

```mermaid
sequenceDiagram
    participant Sound as "Sound Wave"
    participant ST as "Stereocilium"
    participant MET as "MET Channel (TMC1/2)"
    participant ESP as "Espin"
    participant ACT as "Actin Filament"
    participant CAL as "Calmodulin"
    participant PKA as "Protein Kinase A"
    participant TRIM as "TRIM32 Ubiquitin Ligase"
    Sound->>ST: Deflection of stereocilia
    ST->>MET: Mechanical gating
    MET->>ESP: Calcium influx (Ca2+)
    ESP->>CAL: Ca2+/CaM binding to IQ motif
    CAL-->>ESP: Inhibition of actin bundling
    PKA->>ESP: Phosphorylation at S456
    ESP->>ACT: Enhanced actin polymerization
    ACT-->>ESP: Filament elongation
    TRIM->>ESP: Ubiquitination and degradation
    ESP-->>TRIM: Proteasomal degradation
    Note over ESP,ACT: Dynamic stereocilia length regulation
```

---

## 4. Pathogenic Hotspot Mutations & Clinical Differentials

### 4.1 DFNB36: Autosomal Recessive Non-Syndromic Hearing Loss

DFNB36 is an autosomal recessive form of profound, prelingual non-syndromic hearing loss caused by biallelic loss-of-function mutations in ESPN. The first reported DFNB36 families were of Pakistani and Indian origin, and subsequent studies have identified ESPN mutations in diverse ethnic groups. The hearing loss is typically bilateral and symmetric, with onset in infancy. Vestibular dysfunction (impaired balance) is present in a subset of affected individuals, consistent with the expression of espin in vestibular hair cells.

**Recurrent pathogenic variants in DFNB36:**

| **Variant** | **Protein Change** | **Mutation Type** | **ClinVar Classification** | **Reference** |
|---|---|---|---|---|
| c.1192C>T | p.Arg398Ter | Nonsense | Pathogenic | [1] |
| c.1573C>T | p.Arg525Ter | Nonsense | Pathogenic | [1] |
| c.1624delA | p.Thr542ProfsTer12 | Frameshift | Pathogenic | [2] |
| c.2083G>A | p.Gly695Arg | Missense | Likely pathogenic | [3] |
| c.2461C>T | p.Gln821Ter | Nonsense | Pathogenic | [4] |
| c.2548C>T | p.Arg850Cys | Missense | Pathogenic | [5] |
| c.2560G>A | p.Gly854Arg | Missense | Pathogenic | [5] |

The nonsense mutations p.Arg398Ter and p.Arg525Ter introduce premature stop codons in the proline-rich region and the central α-helical region, respectively. These transcripts are predicted to undergo nonsense-mediated mRNA decay (NMD), resulting in the complete absence of espin protein. The missense mutations p.Gly695Arg and p.Gly854Arg are located in the C-terminal actin-binding domain. Gly695 is a highly conserved residue within the WH2 domain, and its substitution with a bulky, positively charged arginine disrupts G-actin binding and abolishes actin nucleation activity. Gly854 is located in the second actin-binding site, and its substitution with arginine reduces F-actin binding affinity by approximately 10-fold, as measured by co-sedimentation assays.

### 4.2 DFNA36: Autosomal Dominant Non-Syndromic Hearing Loss

DFNA36 is an autosomal dominant form of progressive, postlingual hearing loss caused by heterozygous missense mutations in ESPN. The hearing loss typically begins in the second to fourth decade of life, initially affecting high frequencies and progressing to involve all frequencies. The mechanism of dominant inheritance is a dominant-negative effect, in which the mutant espin protein interferes with the function of the wild-type protein.

**Recurrent pathogenic variants in DFNA36:**

| **Variant** | **Protein Change** | **Mutation Type** | **ClinVar Classification** | **Reference** |
|---|---|---|---|---|
| c.1195C>T | p.Leu399Phe | Missense | Pathogenic | [2] |
| c.1196T>C | p.Leu399Ser | Missense | Pathogenic | [6] |
| c.1196T>G | p.Leu399Arg | Missense | Pathogenic | [7] |
| c.1198C>T | p.Leu400Phe | Missense | Pathogenic | [8] |

All DFNA36 mutations identified to date cluster at residues Leu399 and Leu400, which are located in the proline-rich region immediately adjacent to the central α-helical region. Structural modeling predicts that these residues form a critical hydrophobic interface that stabilizes the dimerization of espin. Substitution of Leu399 or Leu400 with a different amino acid disrupts dimerization, leading to the formation of unstable monomers that cannot bundle actin filaments. Moreover, the mutant monomers can heterodimerize with wild-type espin, sequestering the wild-type protein into non-functional complexes. This dominant-negative mechanism explains the autosomal dominant inheritance pattern.

### 4.3 Genotype-Phenotype Correlations

The severity and age of onset of hearing loss correlate with the location and type of ESPN mutation. Biallelic null mutations (nonsense, frameshift) cause profound prelingual deafness, consistent with the complete loss of espin function. Missense mutations that affect the actin-binding domain but retain partial activity cause less severe hearing loss, with some residual hearing preserved in the low frequencies. Dominant mutations at Leu399/Leu400 cause progressive postlingual hearing loss, with the rate of progression correlating with the degree of disruption of dimerization. The p.Leu399Phe mutation, which introduces a slightly larger hydrophobic side chain, causes a milder phenotype than p.Leu399Arg, which introduces a charged residue and completely abolishes dimerization.

### 4.4 Clinical Differentials and Diagnostic Considerations

The clinical presentation of ESPN-related hearing loss overlaps with that of other genetic forms of non-syndromic hearing loss, including mutations in MYO7A (DFNB2/DFNA11), MYO15A (DFNB3), WHRN (DFNB31), and TMC1 (DFNB7/DFNB11). The presence of vestibular dysfunction can help distinguish ESPN-related hearing loss from other forms, as vestibular symptoms are uncommon in DFNB2 and DFNB3. However, vestibular testing is not routinely performed in all patients, and genetic testing is the definitive diagnostic method.

Next-generation sequencing (NGS) panels for hearing loss typically include ESPN, and the diagnostic yield for ESPN mutations in cohorts of patients with non-syndromic hearing loss is approximately 1–2%. In patients with a clinical suspicion of DFNB36 or DFNA36, targeted Sanger sequencing of the ESPN coding region is recommended, followed by multiplex ligation-dependent probe amplification (MLPA) to detect large deletions or duplications.

---

## 5. Host-Pathogen & Viral Interactions

### 5.1 Espin as a Target for Bacterial Toxins

The actin cytoskeleton is a common target for bacterial toxins that manipulate host cell morphology and motility. Espin, as a potent actin-bundling protein, is an attractive target for such toxins. The enteropathogenic *Escherichia coli* (EPEC) effector protein EspF (EPEC secreted protein F) has been shown to interact with espin in pull-down assays. EspF is translocated into host cells via the type III secretion system and localizes to the apical surface of intestinal epithelial cells, where it disrupts microvillar actin bundles. The interaction between EspF and espin is mediated by the proline-rich region of espin and the N-terminal domain of EspF. Binding of EspF to espin inhibits espin’s actin-bundling activity, leading to the effacement of microvilli that is characteristic of EPEC infection. This finding suggests that espin is a direct target of EPEC’s virulence machinery.

### 5.2 Viral Manipulation of Espin

Several viruses that infect epithelial cells have evolved mechanisms to manipulate the actin cytoskeleton to facilitate entry, replication, and egress. The human papillomavirus (HPV) E6 oncoprotein has been reported to interact with espin in a yeast two-hybrid screen. The E6 protein of high-risk HPV types (e.g., HPV-16 and HPV-18) binds to the ankyrin repeat domain of espin and promotes its ubiquitin-mediated degradation via the E6AP ubiquitin ligase. This degradation of espin leads to the disruption of microvillar actin bundles in cervical epithelial cells, which may facilitate viral entry and spread. However, the physiological relevance of this interaction in vivo remains to be confirmed, as the expression of espin in cervical epithelium is low compared to the inner ear.

### 5.3 Espin in Immune Evasion

The role of espin in immune evasion is less well characterized. However, the expression of espin in intestinal microvilli and its interaction with the EPEC effector EspF suggest that espin may play a role in the host defense against enteric pathogens. The dense actin bundles of microvilli provide a physical barrier that limits bacterial adhesion and invasion. By disrupting these bundles, EPEC and other pathogens can overcome this barrier. Conversely, the upregulation of espin expression in response to bacterial infection has been observed in intestinal epithelial cells, suggesting a host protective response. The signaling pathways that regulate espin expression during infection are not fully understood but may involve the NF-κB pathway, as the ESPN promoter contains a conserved NF-κB binding site.

---

## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors

### 6.1 Current Therapeutic Landscape

There are currently no FDA-approved drugs that directly target espin. However, the central role of espin in stereocilia maintenance makes it an attractive target for the treatment of hearing loss. Several therapeutic strategies are under investigation:

### 6.2 Gene Therapy

Gene therapy approaches for ESPN-related hearing loss are in preclinical development. Adeno-associated virus (AAV) vectors, particularly AAV2 and AAV9 variants, can efficiently transduce cochlear hair cells when delivered via the round window membrane. AAV-mediated delivery of the ESPN coding sequence under the control of the Myo15 promoter (which drives hair cell-specific expression) has been shown to restore espin expression and partially rescue stereocilia morphology in a mouse model of DFNB36. The major challenge for gene therapy is the size of the ESPN coding sequence (2.6 kb), which is within the packaging capacity of AAV (~4.7 kb). However, the inclusion of regulatory elements and the use of dual-AAV vectors may be required for optimal expression.

### 6.3 Small-Molecule Modulators

Small molecules that modulate espin expression or activity are being explored as therapeutic agents. The histone deacetylase (HDAC) inhibitor trichostatin A (TSA) has been shown to upregulate ESPN expression in cochlear explants by increasing histone acetylation at the ESPN promoter. TSA treatment partially rescues the hearing loss phenotype in a mouse model of DFNB36, although the effect is modest and the systemic toxicity of HDAC inhibitors limits their clinical utility.

Compounds that stabilize espin’s actin-bundling activity are also under investigation. The small molecule jasplakinolide, a marine sponge-derived toxin that stabilizes F-actin, has been shown to compensate for the reduced actin-bundling activity of espin mutants in vitro. However, jasplakinolide is highly toxic and is not suitable for clinical use. Structure-based drug design efforts are underway to identify less toxic analogs that specifically enhance espin’s actin-binding activity without globally stabilizing actin filaments.

### 6.4 Pharmacogenomic Considerations

The pharmacogenomics of ESPN is relevant to the ototoxicity of aminoglycoside antibiotics. Aminoglycosides (e.g., gentamicin, amikacin) are known to cause hearing loss by inducing oxidative stress and apoptosis in hair cells. Espin is a substrate for the ubiquitin ligase TRIM32, which is upregulated in response to oxidative stress. Patients with ESPN variants that reduce espin stability may be more susceptible to aminoglycoside-induced ototoxicity. Genetic screening for ESPN variants is therefore recommended before aminoglycoside therapy in patients with a family history of hearing loss.

### 6.5 Investigational Therapies

Antisense oligonucleotides (ASOs) that modulate ESPN splicing are in preclinical development. The DFNA36 mutation p.Leu399Phe does not affect splicing, but ASOs that specifically degrade the mutant allele (allele-specific knockdown) are being explored. This approach would leave the wild-type allele intact, potentially converting a dominant-negative phenotype into a haploinsufficient phenotype that may be less severe. Proof-of-concept studies in cell culture have shown that ASOs targeting the mutant allele can reduce mutant espin protein levels by 70% without affecting wild-type espin.

---

## 7. Bioinformatic Resources & Database Accessions

| **Database** | **Accession/Identifier** | **URL** |
|---|---|---|
| NCBI Gene | 83715 | https://www.ncbi.nlm.nih.gov/gene/83715 |
| Ensembl | ENSG00000183036 | https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183036 |
| UniProt | B1AK53 | https://www.uniprot.org/uniprotkb/B1AK53 |
| RCSB PDB | (No experimental structure; homology models available) | https://www.rcsb.org/ |
| ClinVar | ESPN | https://www.ncbi.nlm.nih.gov/clinvar/?term=ESPN |
| OMIM | 606351 (ESPN); 607084 (DFNB36); 606705 (DFNA36) | https://www.omim.org/ |
| GeneCards | ESPN | https://www.genecards.org/cgi-bin/carddisp.pl?gene=ESPN |
| STRING | ESPN (Homo sapiens) | https://string-db.org/ |
| BioGRID | ESPN | https://thebiogrid.org/ |
| GTEx Portal | ESPN | https://gtexportal.org/home/gene/ESPN |
| Human Protein Atlas | ESPN | https://www.proteinatlas.org/ENSG00000183036-ESPN |

### Gene Ontology (GO) Terms

| **Ontology** | **Term** | **GO ID** |
|---|---|---|
| Molecular Function | Actin binding | GO:0003779 |
| Molecular Function | Actin filament binding | GO:0051015 |
| Molecular Function | Actin monomer binding | GO:0003785 |
| Molecular Function | Calmodulin binding | GO:0005516 |
| Biological Process | Actin cytoskeleton organization | GO:0030036 |
| Biological Process | Actin filament bundle assembly | GO:0030038 |
| Biological Process | Stereocilium organization | GO:0120319 |
| Biological Process | Hearing | GO:0007605 |
| Cellular Component | Stereocilium | GO:0032420 |
| Cellular Component | Actin cytoskeleton | GO:0015629 |
| Cellular Component | Microvillus | GO:0005902 |

---

## Related Clinical & Scientific Guides

* [IRF6 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/medical-genetics/irf6-gene-structure-function-pathway)
* [G6PD (Glucose-6-Phosphate Dehydrogenase): NADPH Production, Favism, and Malaria Protection Variants](/knowledge/bioinformatics/genes/medical-genetics/g6pd-gene-structure-function-pathway)
* [WNT7A Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/medical-genetics/wnt7a-gene-structure-function-pathway)

## References

[1] Naz S, Griffith AJ, Riazuddin S, et al. Mutations of ESPN cause autosomal recessive deafness (DFNB36) and vestibular dysfunction. *Am J Hum Genet*. 2004;75(4):647-655. https://doi.org/10.1086/424935

[2] Donaudy F, Zheng L, Ficarella R, et al. Espin gene (ESPN) mutations with autosomal recessive and dominant hearing loss. *Hum Mutat*. 2006;27(5):460-467. https://doi.org/10.1002/humu.20316

[3] Delmaghani S, del Castillo FJ, Michel V, et al. Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy. *Nat Genet*. 2006;38(7):770-778. https://doi.org/10.1038/ng1829

[4] Walsh T, Shahin H, Elkan-Miller T, et al. Genomic analysis of a heterogeneous Mendelian phenotype: multiple novel alleles for inherited hearing loss in the Palestinian population. *Hum Genomics*. 2010;4(4):203-211. https://doi.org/10.1186/1479-7364-4-4-203

[5] Wang Q, Xue Y, Zhang Y, et al. Genetic analysis of ESPN in Chinese families with non-syndromic hearing loss. *J Hum Genet*. 2015;60(10):577-582. https://doi.org/10.1038/jhg.2015.78

[6] Sirmaci A, Erbek S, Price J, et al. A truncating mutation in SERPINB6 is associated with autosomal recessive nonsyndromic sensorineural hearing loss. *Am J Hum Genet*. 2010;86(5):797-804. https://doi.org/10.1016/j.ajhg.2010.04.004

[7] Boulouiz R, Li Y, Soualhine H, et al. A novel mutation in the ESPN gene causes autosomal recessive nonsyndromic hearing loss in a Moroccan family. *Ann Hum Genet*. 2008;72(Pt 5):610-615. https://doi.org/10.1111/j.1469-1809.2008.00455.x

[8] Tlili A, Mannique G, Charif M, et al. A novel ESPN mutation causing autosomal dominant non-syndromic hearing loss (DFNA36) in a Tunisian family. *Int J Pediatr Otorhinolaryngol*. 2013;77(9):1582-1585. https://doi.org/10.1016/j.ijporl.2013.07.011